CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.295 |
Evidence |
|
ELAVL1 |
ELAVL1, HUR: ELAV-like protein 1 |
FUBP1 |
IPI00375441 |
0.295 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
0.295 |
Evidence |
|
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.295 |
Evidence |
|
CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
0.295 |
Evidence |
|
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
0.295 |
Evidence |
|
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
SORL1 |
SORL1: Sortilin-related receptor precursor |
0.295 |
Evidence |
|
CXorf9 |
IPI00004504 |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.295 |
Evidence |
|
IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.295 |
Evidence |
|
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
0.295 |
Evidence |
|
ANXA1 |
ANXA1, ANX1, LPC1: Annexin A1 |
CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
0.295 |
Evidence |
|
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
TMSB10 |
TMSB10, PTMB10, THYB10: Thymosin beta-10 |
0.292 |
Evidence |
|
NEK2 |
NEK2, NLK1: Serine/threonine-protein kinase Nek2 |
CDKN3 |
CDKN3, CDI1, CIP2, KAP: Cyclin-dependent kinase inhibitor 3 |
0.292 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
LIPC |
LIPC, HTGL: Hepatic triacylglycerol lipase precursor |
0.292 |
Evidence |
|
BAI3 |
BAI3, KIAA0550: Brain-specific angiogenesis inhibitor 3 precursor |
LGI1 |
LGI1, EPT, UNQ775/PRO1569: Leucine-rich glioma-inactivated protein 1 precursor |
0.292 |
Evidence |
|
LSM7 |
LSM7: U6 snRNA-associated Sm-like protein LSm7 |
GTF3C2 |
GTF3C2, KIAA0011: General transcription factor 3C polypeptide 2 |
0.292 |
Evidence |
|
SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
NUP37 |
NUP37: Nucleoporin Nup37 |
0.292 |
Evidence |
|
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
NUP37 |
NUP37: Nucleoporin Nup37 |
0.292 |
Evidence |
|
BAI3 |
BAI3, KIAA0550: Brain-specific angiogenesis inhibitor 3 precursor |
C9orf30 |
TMEFF1, C9orf2: Tomoregulin-1 precursor |
0.292 |
Evidence |
|
ZCCHC14 |
ZCCHC14, KIAA0579: Zinc finger CCHC domain-containing protein 14 |
DDX25 |
DDX25, GRTH: ATP-dependent RNA helicase DDX25 |
0.292 |
Evidence |
|
FOXA1 |
FOXA1, HNF3A, TCF3A: Hepatocyte nuclear factor 3-alpha |
HOXB13 |
HOXB13: Homeobox protein Hox-B13 |
0.292 |
Evidence |
|
C8A |
C8A: Complement component C8 alpha chain precursor |
LIPC |
LIPC, HTGL: Hepatic triacylglycerol lipase precursor |
0.292 |
Evidence |
|
BAI3 |
BAI3, KIAA0550: Brain-specific angiogenesis inhibitor 3 precursor |
NRXN1 |
NRXN1: Neurexin-1-beta precursor |
0.292 |
Evidence |
|
SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
WDR12 |
WDR12: WD repeat-containing protein 12 |
0.292 |
Evidence |
|
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
GTF3C2 |
GTF3C2, KIAA0011: General transcription factor 3C polypeptide 2 |
0.292 |
Evidence |
|